```html

Kiss Syndrome (Postural Tachycardia)

What is Kiss syndrome (postural tachycardia)?

Kiss syndrome, more formally known as postural tachycardia syndrome (POTS), is a form of dysautonomia—a disorder of the autonomic nervous system—that causes an abnormal increase in heart rate when a person moves from a lying‑down to a standing position. The name “KISS” comes from the acronym “Kinetic Increase of Standing Speed,” a descriptive term coined by early researchers to highlight the core physiological feature.

In a healthy adult, standing causes the heart rate to rise by 10–15 beats per minute (bpm) as blood pools in the legs. In POTS, the heart rate jumps ≥30 bpm (or >120 bpm total) within ten minutes of standing, without a corresponding drop in blood pressure. This exaggerated response leads to a constellation of symptoms that can be disabling and often overlap with anxiety, chronic fatigue, and other conditions.

According to the Mayo Clinic and the National Institute of Neurological Disorders and Stroke (NINDS), POTS affects an estimated 0.2 % of the U.S. population, predominantly women between the ages of 15–45 years.<sup>1,2</sup>

Common Causes

While the exact cause of POTS remains incompletely understood, several underlying conditions and triggers have been identified. The following list includes the most frequently cited contributors:

• Autoimmune disorders – e.g., Sjögren’s syndrome, Hashimoto thyroiditis.
• Peripheral neuropathy – especially small‑fiber neuropathy that impairs vasoconstriction.
Genetic predisposition – hereditary forms linked to mutations in the FLNA or RNF213 genes.
• Hyperadrenergic state – excess norepinephrine release on standing.
• Hypovolemia – low blood volume due to chronic dehydration, diuretic over‑use, or gastrointestinal loss.
• Post‑viral syndrome – many patients report onset after Epstein‑Barr virus, COVID‑19, or other viral infections.
• Physical deconditioning – prolonged bed rest, chronic fatigue syndrome, or sedentary lifestyle.
• Ehlers‑Danlos syndrome (hypermobile type) – connective‑tissue laxity impacts vascular tone.
• Medication‑induced – beta‑agonists, certain antidepressants, or diuretics can precipitate POTS.
• Pregnancy – hormonal changes and increased blood volume may unmask or worsen symptoms.

Associated Symptoms

POTS is a multisystem disorder, so patients often experience a wide range of secondary complaints. Commonly reported symptoms include:

• Light‑headedness or dizziness on standing
• Palpitations or “racing” heart
• Fatigue that worsens after upright activity
• Headache, often described as “brain fog” or concentration difficulty
• Blurred vision or “tunnel vision”
• Nausea, abdominal cramping, or early satiety
• Temperature intolerance – feeling hot or cold without obvious cause
• Chest discomfort (usually non‑ischemic)
• Joint hypermobility or musculoskeletal pain (particularly in those with Ehlers‑Danlos)
• Sleep disturbances, including insomnia or restless leg syndrome

When to See a Doctor

Because the symptoms overlap with many other conditions, it is important to seek professional evaluation if you notice any of the following:

• Heart rate rises by 30 bpm or more (or exceeds 120 bpm) within 10 minutes of standing.
• Frequent dizziness, fainting, or near‑fainting episodes.
• Chest pain, shortness of breath, or severe palpitations.
• Persistent fatigue that interferes with work or school.
• Symptoms that do not improve with simple measures such as fluid intake or compression stockings.
• New or worsening neurological signs (e.g., severe tremor, confusion).

Early consultation with a primary‑care physician, cardiologist, or neurologist experienced in dysautonomia can shorten the diagnostic journey and prevent complications.

Diagnosis

Diagnosing POTS requires a combination of clinical history, physical examination, and objective testing. The typical work‑up follows these steps:

1. Detailed History & Physical

• Symptom chronology, triggers, and impact on daily life.
• Medication review and family history of autonomic or autoimmune disease.
• Orthostatic vital signs (heart rate & blood pressure) taken while supine, then at 1‑, 3‑, 5‑, and 10‑minute intervals after standing.

2. Tilt‑Table Test

The gold‑standard diagnostic tool. The patient lies on a motorized table that tilts to 70°–80° while continuous ECG and blood pressure monitoring occur. A sustained heart‑rate increase of ≥30 bpm (≥40 bpm if the patient is under 19 years) without orthostatic hypotension confirms POTS.

3. Laboratory Evaluation

• Complete blood count, metabolic panel, thyroid function, and vitamin B12 – to rule out anemia, electrolyte imbalance, or thyroid disease.
• Serum norepinephrine (especially in the upright position) – helps identify hyperadrenergic POTS.
• Autoimmune panel (ANA, SSA/SSB, anti‑phospholipid antibodies) if an autoimmune trigger is suspected.

4. Additional Tests (as indicated)

• 24‑hour Holter monitor – to document arrhythmias.
• Cardiac ultrasound – to evaluate structural heart disease.
• Skin biopsy – for small‑fiber neuropathy.
• Genetic testing – when a hereditary form is suspected.

Both the American College of Cardiology and the Cleveland Clinic endorse this tiered approach, emphasizing that a positive tilt‑table test must be interpreted in the clinical context.<sup>3,4</sup>

Treatment Options

Management of POTS is individualized. The primary goals are to reduce heart‑rate spikes, improve blood volume, and alleviate symptoms. Treatment usually combines lifestyle modifications, non‑pharmacologic measures, and, when needed, medication.

Non‑Pharmacologic (Home) Strategies

• Fluid and Salt Loading – Aim for 2–3 L of water and 3–5 g of sodium per day (under physician guidance).
• Compression Garments – Knee‑high or waist‑high stockings (30–40 mmHg) to reduce venous pooling.
• Physical Reconditioning – A graduated aerobic program starting with recumbent exercise (e.g., rowing, swimming) and progressing to upright activities.
• Meal Planning – Small, frequent meals; avoid large carbohydrate loads that can provoke post‑prandial tachycardia.
• Sleep Hygiene – Elevate the head of the bed 6–10 cm to lessen nocturnal blood‑volume shifts.
• Stress Management – Mind‑body techniques (yoga, meditation) reduce sympathetic over‑activity.

Medication Options

Medications are reserved for patients who remain symptomatic after lifestyle changes.

• Beta‑blockers (e.g., propranolol, atenolol) – Lower heart rate and blunt catecholamine effects.
• Ivabradine – Selective sinus‑node inhibitor that reduces heart rate without affecting blood pressure.
• Fludrocortisone – A mineralocorticoid that expands plasma volume; monitor electrolytes.
• Pyridostigmine – Enhances ganglionic acetylcholine, improving autonomic tone.
• Midodrine – Alpha‑agonist that raises standing blood pressure; useful when orthostatic intolerance co‑exists.
• Selective Serotonin Reuptake Inhibitors (SSRIs) / SNRIs – May help hyperadrenergic POTS by modulating central sympathetic output.
• Clonidine – Central alpha‑2 agonist; considered for severe hyperadrenergic states.

All medication decisions should be made with a clinician familiar with dysautonomia, as side‑effects (e.g., fatigue from beta‑blockers) can worsen quality of life.

Other Therapeutic Modalities

• Intravenous saline infusions – Short‑term boost in volume for severe cases.
• Physical therapy – Tailored programs that emphasize core strength and proprioception.
• Psychological support – Cognitive‑behavioral therapy (CBT) to address anxiety or depression that often co‑exists.

Prevention Tips

While a definitive primary prevention for POTS is not possible, certain measures can lower the risk of symptom exacerbation or perhaps delay onset in susceptible individuals:

• Stay well‑hydrated and maintain adequate salt intake, especially during hot weather or after illness.
• Avoid prolonged bed rest; incorporate gentle movement even during recovery from illness.
• Limit caffeine and alcohol, which can destabilize autonomic tone.
• Gradually increase physical activity rather than sudden intense exertion.
• Manage chronic infections promptly; treat Lyme disease, EBV, or COVID‑19 complications under medical supervision.
• If you have a known connective‑tissue disorder (e.g., Ehlers‑Danlos), follow specialist‑recommended cardiovascular monitoring.

Emergency Warning Signs

Key Take‑aways

Kiss syndrome (postural tachycardia syndrome) is a treatable autonomic disorder that primarily affects young women but can occur at any age. Understanding the underlying triggers, recognizing associated symptoms, and pursuing a structured diagnostic work‑up are essential first steps. With a combination of fluid‑salt strategies, compression therapy, graduated exercise, and targeted medications, most patients achieve meaningful symptom reduction and an improved quality of life.

References:

1. Mayo Clinic. “Postural tachycardia syndrome (POTS).” Accessed April 2024. https://www.mayoclinic.org
2. National Institute of Neurological Disorders and Stroke. “Postural Tachycardia Syndrome Fact Sheet.” Updated 2023. https://www.ninds.nih.gov
3. American College of Cardiology. “Guidelines for the Diagnosis and Management of POTS.” JACC, 2022. DOI:10.1016/j.jacc.2022.03.032
4. Cleveland Clinic. “Postural Tachycardia Syndrome (POTS).” Patient Education, 2023. https://my.clevelandclinic.org
5. Raj, S. R. “Management of Postural Tachycardia Syndrome.” *Current Treatment Options in Neurology*, 2021. PMID: 33821561.

```